qimono / Pixabay
The FDA Has Awarded Fast Track Designation to an Investigational Drug For Certain Forms of Ovarian Cancer
The United States FDA has awarded Fast Track Designation to the investigational drug AVB-S6-500 for the potential treatment of platinum-resistant recurrent ovarian cancer. You can find out more detailed information…
Continue Reading
The FDA Has Awarded Fast Track Designation to an Investigational Drug For Certain Forms of Ovarian Cancer
